Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Health After The GLP-1 Collapse
08:47am, Tuesday, 24'th Feb 2026
Hims & Hers Health's revenue grew 59% to $2.35B in 2025, while adjusted EBITDA surged nearly 80% to $318M. Operating cash flow reached $300M, with $929M in liquidity, reinforcing balance sheet strengt
Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences
08:32am, Tuesday, 24'th Feb 2026
The stock's decline follows a report that revealed revenue missed analyst expectations, adding pressure as broader markets experienced slight gains on the previous trading day.
Wall Street Breakfast Podcast: FedEx Demands Tariffs Return To Sender
06:40am, Tuesday, 24'th Feb 2026
FedEx (FDX) is suing the U.S. for a full refund of IEEPA tariffs after a Supreme Court ruling, with potential industry-wide implications. Hims & Hers Health (HIMS) disclosed an SEC investigation into
Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall
06:40am, Tuesday, 24'th Feb 2026
Hims & Hers Health (NYSE: HIMS) delivered a beat on both earnings and profitability in Q4 2025, though a soft 2026 revenue guidance is keeping the stock under pressure after a sharp year-to-date sello
Hims & Hers Q4 Earnings Show Growth Amid GLP-1 Scrutiny
06:30am, Tuesday, 24'th Feb 2026
Hims & Hers Health delivered strong FY25 results with 59% revenue growth to $2.35B and 13% subscriber growth, but faces near-term margin pressure. Management guided FY26 revenue of $2.7–$2.9B and Ad
Hims & Hers Q4 EPS Beats; Soft 2026 Outlook
06:22am, Tuesday, 24'th Feb 2026
Hims and Hers Health, Inc. (HIMS, Financials) reported fourth quarter GAAP earnings per share of $0.08, topping estimates by $0.03, as revenue increased 28.4% fro
Hims Expands Globally, Guides Higher
06:12am, Tuesday, 24'th Feb 2026
Hims and Hers Health, Inc. (HIMS) is setting an ambitious tone for 2026, projecting revenue of $2.7 billion 2.9 billion as it pushes deeper into new specialties a
Hims & Hers Falls on Soft Q1 Revenue Guidance
06:04am, Tuesday, 24'th Feb 2026
Hims and Hers Health (HIMS) shares are down 6.71% to $14.47 in pre-market trading after the company released its fourth-quarter results. Revenue for the quarter c
Hims & Hers Health, Inc. (HIMS) Q4 2025 Earnings Call Transcript
09:25pm, Monday, 23'rd Feb 2026
Hims & Hers Health, Inc. (HIMS) Q4 2025 Earnings Call Transcript
Hims & Hers Health, Inc. (HIMS) Surpasses Q4 Earnings Estimates
08:26pm, Monday, 23'rd Feb 2026
Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.11 per share a year ago.
Hims & Hers' expansion plans — as well as its Super Bowl ad — have investors worried about profits
07:44pm, Monday, 23'rd Feb 2026
The wellness platform's results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business.
Hims & Hers Health Fourth-Quarter Profit Falls Despite Higher Revenue
04:31pm, Monday, 23'rd Feb 2026
The telehealth platform posted a quarterly profit of $20.6 million, down from $26 million a year earlier.
Hims & Hers Health Reports Mixed Q4 Earnings, Subscribers Cross 2.5 Million
04:26pm, Monday, 23'rd Feb 2026
Hims & Hers Health reported fourth-quarter revenue of $617.82 million, missing analyst estimates of $619.22 million. The company reported fourth-quarter earnings of eight cents per share, beating es
Hims & Hers Stock Falls. Why Earnings Are Underwhelming Investors.
04:25pm, Monday, 23'rd Feb 2026
Hims & Hers, the telehealth provider best known for its compounded weight-loss drugs, issues a weak outlook.
Hims & Hers forecasts 2026 revenue above estimates
04:15pm, Monday, 23'rd Feb 2026
Hims & Hers Health forecast 2026 revenue above estimates on Monday, betting on increased sales for its personalized healthcare offerings.
